Robert Hofstadter

Nobel laureate Robert Hofstadter, 75, died November 17 at his home in Stanford, Calif., after a long bout with heart disease. Hofstadter's early investigations, in which he measured the size of the neutron and proton in the nuclei of atoms, won him the Nobel Prize in physics in 1961. Hofstadter was one of the driving forces behind the creation of the Stanford Linear Accelerator. He also made substantial contributions to gamma ray spectroscopy, leading to the use of radioactive tracers to locate

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Nobel laureate Robert Hofstadter, 75, died November 17 at his home in Stanford, Calif., after a long bout with heart disease. Hofstadter's early investigations, in which he measured the size of the neutron and proton in the nuclei of atoms, won him the Nobel Prize in physics in 1961. Hofstadter was one of the driving forces behind the creation of the Stanford Linear Accelerator. He also made substantial contributions to gamma ray spectroscopy, leading to the use of radioactive tracers to locate tumors and other disorders. Hofstadter earned his B.S. in 1935 at the City College of New York, and earned his Ph.D. in physics in 1938 at Princeton University. During World War II, following postdoctoral work at the University of Pennsylvania, he worked as a physicist at the National Bureau of Standards, where he helped develop the proximity fuse, an antiaircraft weapon.

In 1950, Hofstadter joined the faculty of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies